Global Market for Diabetes Therapeutics and Diagnostics

April 21, 2008

The global market for diabetes therapeutics and diagnostics is estimated at US$214 billion in 2008. This is expected to increase to more than $242 billion by 2013, a compound average annual growth rate of 2.5%. These are the findings of BCC Research (Wellesley, MA, USA), a publisher of market research reports and technical publications.¹

read more | digg story

¹Medinews.com

Bookmark and Share
StumbleUpon


Singapore’s BTI signs pact with Raven

April 8, 2008

*Updated with a more detailed article*

New Article Linked Below

read more | digg story

¹BioSpectrum Bureau©

Bookmark and Share
StumbleUpon


Singapore Bioprocessing Technology Institute join hands with Raven to develop medicine for the future

April 7, 2008

Collaboration will boost monoclonal antibody R&D and develop novel stem cell antibodies for diagnostic and therapeutic applications.¹

Read More | digg story

¹Government of Singapore, Press Release

Bookmark and Share
StumbleUpon


Global Market for Diabetes Therapeutics and Diagnostics Worth $241.9 Billion by 2013

April 3, 2008

Global Market for Diabetes Therapeutics and Diagnostics Worth $241.9 Billion by 2013

Wellesley, Mass—According to a new technical market research report, Diabetes Therapies & Diagnostics: Global Markets (HLC029B) from BCC Research (www.bccresearch.com), the global market for diabetes therapeutics and diagnostics will be worth $213.8 billion in 2008. This is expected to increase to over $241.9 billion by 2013, a compound average annual growth rate (CAGR) of 2.5%. 

Bookmark and Share
StumbleUpon